Trending Stock News

Bank Of America (BAC) Holder Oregon Public Employees Retirement Fund Has Trimmed Its Position; Gilead Sciences Com (GILD) Position Held by American National Bank

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

American National Bank increased its stake in Gilead Sciences Inc. Com (GILD) by 49.41% based on its latest 2018Q1 regulatory filing with the SEC. American National Bank bought 16,090 shares as the company’s stock declined 17.62% with the market. The institutional investor held 48,657 shares of the health care company at the end of 2018Q1, valued at $3.67M, up from 32,567 at the end of the previous reported quarter. American National Bank who had been investing in Gilead Sciences Inc. Com for a number of months, seems to be bullish on the $92.41 billion market cap company. The stock decreased 0.63% or $0.45 during the last trading session, reaching $71.07. About 4.11M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 4.37% since June 24, 2017 and is uptrending. It has underperformed by 8.20% the S&P500. Some Historical GILD News: 30/05/2018 – GALAPAGOS NV – THERE WERE NO CASES OF OPPORTUNISTIC INFECTION, TUBERCULOSIS, THROMBOEMBOLISM, OR MALIGNANCY IN TRIAL; 30/05/2018 – GILEAD SCIENCES INC – CHINA DRUG ADMINISTRATION APPROVES EPCLUSA(SOFOSBUVIR/VELPATASVIR), GILEAD’S PAN-GENOTYPIC TREATMENT FOR CHRONIC HEPATITIS C VIRUS INFECTION; 05/03/2018 – GLAXOSMITHKLINE PLC – VIIV HEALTHCARE ANNOUNCES POSITIVE NEW DOLUTEGRAVIR DATA FOR TREATMENT OF PEOPLE LIVING WITH HIV CO-INFECTED WITH TUBERCULOSIS; 30/04/2018 – Gilead and Verily Announce Scientific Collaboration on Immunological and Molecular Drivers of Inflammatory Diseases; 05/03/2018 – Gilead Sciences: No Patients in Biktarvy Treatment Arm Demonstrated Treatment-Emergent Resistance Through 48 Weeks; 02/04/2018 – Gilead’s Descovy Falls After 1-Wk Rise, Odefsey Declines: HIV; 05/03/2018 ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-lnfected With Tuberculosis; 25/04/2018 – GILEAD HAD BEEN SUED BY MERCK OVER ITS HEPATITIS DRUGS; 15/03/2018 – STAT Plus: HHS is urged to investigate a Gilead hepatitis C patent for failing to disclose federal funding; 21/05/2018 – Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1

Oregon Public Employees Retirement Fund decreased its stake in Bank Of America Corp (BAC) by 12.19% based on its latest 2018Q1 regulatory filing with the SEC. Oregon Public Employees Retirement Fund sold 463,286 shares as the company’s stock declined 6.97% with the market. The institutional investor held 3.34M shares of the major banks company at the end of 2018Q1, valued at $100.12M, down from 3.80M at the end of the previous reported quarter. Oregon Public Employees Retirement Fund who had been investing in Bank Of America Corp for a number of months, seems to be less bullish one the $293.94B market cap company. The stock decreased 1.02% or $0.3 during the last trading session, reaching $28.99. About 77.35 million shares traded or 15.78% up from the average. Bank of America Corporation (NYSE:BAC) has risen 29.72% since June 24, 2017 and is uptrending. It has outperformed by 17.15% the S&P500. Some Historical BAC News: 03/05/2018 – CATERPILLAR INC CAT.N : BOFA MERRILL CUTS PRICE OBJECTIVE TO $156 FROM $172; 29/03/2018 – BANK OF AMERICA SAYS 600 NEW MERRILL EDGE INVESTMENT CENTERS WILL BE ADDED TO NEW AND EXISTING BANK OF AMERICA FINANCIAL CENTER LOCATIONS; 09/05/2018 – VISHAY INTERTECHNOLOGY INC VSH.N : BOFA MERRIL RAISES TO BUY FROM UNDERPERFORM – TRADERS; 12/04/2018 – U.S. senator slams bank gun policies, threatens consumer complaint; 13/03/2018 – SUPER MICRO COMPUTER – NEW DEBT FACILITY, TO BE LED BY BOFA MERRILL LYNCH, IS EXPECTED TO INCLUDE OTHER LENDERS & INCREASE CO’S BORROWING CAPACITY; 06/04/2018 – MAIDEN HOLDINGS APPOINTS BOFA MERRILL LYNCH TO MANAGE STRATEGIC REVIEW PROCESS; 02/05/2018 – NanoString Presenting at Bank of America Conference May 15; 16/04/2018 – BOFA CFO:`ERICA’ ARTIFICIAL INTELLIGENCE PROGRAM INSTALLED 1Q18; 16/04/2018 – BANK OF AMERICA CORP – QTRLY NONINTEREST INCOME INCREASED $327 MILLION, OR 3%, TO $11.5 BILLION; 14/05/2018 – Mednax Presenting at Bank of America Conference May 17

American National Bank, which manages about $347.96M US Long portfolio, decreased its stake in Verizon Communications Com (NYSE:VZ) by 8,355 shares to 112,970 shares, valued at $5.40 million in 2018Q1, according to the filing. It also reduced its holding in American Airlines Group (NASDAQ:AAL) by 52,805 shares in the quarter, leaving it with 37 shares, and cut its stake in Roper Industries Inc (NYSE:ROP).

Among 31 analysts covering Gilead Sciences (NASDAQ:GILD), 22 have Buy rating, 0 Sell and 9 Hold. Therefore 71% are positive. Gilead Sciences had 132 analyst reports since July 29, 2015 according to SRatingsIntel. Maxim Group maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, July 27 with “Hold” rating. The firm has “Buy” rating given on Wednesday, May 2 by RBC Capital Markets. The rating was downgraded by Citigroup to “Neutral” on Wednesday, February 8. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Wednesday, October 4 by Oppenheimer. Barclays Capital maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, May 2 with “Overweight” rating. The firm has “Strong Buy” rating given on Thursday, September 10 by Jyske Bank. The firm has “Hold” rating given on Wednesday, September 9 by Jefferies. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, October 4. Jefferies has “Hold” rating and $93 target. Piper Jaffray maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Tuesday, July 25. Piper Jaffray has “Buy” rating and $8900 target. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Overweight” rating by PiperJaffray on Thursday, May 31.

Since January 2, 2018, it had 0 insider purchases, and 23 insider sales for $48.21 million activity. WILSON GAYLE E also sold $4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares. 5,833 shares were sold by Cogan John Francis, worth $430,130 on Friday, April 20. 100,000 shares were sold by Meyers James R, worth $8.02M. Alton Gregg H sold $1.11 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, January 2. 5,000 shares were sold by Washington Robin L, worth $401,566.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead Sciences, Inc. (GILD) Presents at Goldman Sachs 39th Annual Global Healthcare Conference (Transcript)” on June 13, 2018, also Benzinga.com with their article: “Cramer: Gilead Is Dead Money” published on June 01, 2018, Seekingalpha.com published: “Gilead Oncology CAR T-Cell Therapies Outlook Compelling” on June 18, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Tesaro: Consider Calls” published on June 19, 2018 as well as Fool.com‘s news article titled: “ASCO Conference Preview: Here’s What Biotech Investors Need to Watch” with publication date: May 31, 2018.

Investors sentiment increased to 0.88 in Q1 2018. Its up 0.08, from 0.8 in 2017Q4. It increased, as 71 investors sold GILD shares while 519 reduced holdings. 114 funds opened positions while 404 raised stakes. 976.44 million shares or 0.39% more from 972.68 million shares in 2017Q4 were reported. Parsons Capital Mgmt Ri holds 11,815 shares. Utd Asset Strategies reported 1.44% in Gilead Sciences, Inc. (NASDAQ:GILD). Continental Advsr Ltd accumulated 1% or 52,500 shares. Endurance Wealth Mngmt holds 0.3% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 23,287 shares. State Treasurer State Of Michigan holds 4.21M shares or 2.56% of its portfolio. The California-based Cetera Advisor Ntwk Limited Liability Company has invested 0.11% in Gilead Sciences, Inc. (NASDAQ:GILD). Tarbox Family Office has 0.19% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Sentinel Company Lba reported 20,655 shares. Legg Mason Asset Mgmt (Japan) stated it has 0.29% in Gilead Sciences, Inc. (NASDAQ:GILD). Rodgers Brothers Incorporated owns 16,150 shares for 0.4% of their portfolio. Walleye Trading Ltd Company invested in 169,483 shares. Sei Invests stated it has 0.09% in Gilead Sciences, Inc. (NASDAQ:GILD). Mark Sheptoff Fincl Planning Limited reported 8,887 shares or 0.46% of all its holdings. Oakworth Capital Inc, a Alabama-based fund reported 7,310 shares. Ajo LP invested in 0.17% or 483,758 shares.

More notable recent Bank of America Corporation (NYSE:BAC) news were published by: Seekingalpha.com which released: “US banks may boost payouts by $30B after stress tests: Bloomberg” on June 19, 2018, also Finance.Yahoo.com with their article: “Thursday’s Vital Data: Micron Technology, Inc. (MU), Bank of America Corp (BAC) and AbbVie Inc. (ABBV)” published on May 31, 2018, Fool.com published: “How Wells Fargo Is Following in Bank of America’s Footsteps” on June 11, 2018. More interesting news about Bank of America Corporation (NYSE:BAC) were released by: Seekingalpha.com and their article: “Bank Of America Comprehensive Capital Analysis And Review: Expect A 75% Dividend Hike” published on June 22, 2018 as well as Investorplace.com‘s news article titled: “5 Top Stock Trades for Thursday Morning” with publication date: June 13, 2018.

Among 33 analysts covering Bank of America (NYSE:BAC), 22 have Buy rating, 0 Sell and 11 Hold. Therefore 67% are positive. Bank of America had 114 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained it with “Buy” rating and $2800 target in Friday, August 11 report. Robert W. Baird downgraded the stock to “Neutral” rating in Wednesday, November 16 report. The firm has “Buy” rating given on Thursday, December 21 by Keefe Bruyette & Woods. The company was upgraded on Tuesday, September 1 by Bernstein. Bernstein upgraded Bank of America Corporation (NYSE:BAC) on Tuesday, August 25 to “Mkt Perform” rating. The company was upgraded on Tuesday, August 25 by Macquarie Research. The stock of Bank of America Corporation (NYSE:BAC) has “Outperform” rating given on Friday, January 29 by CLSA. The stock has “Buy” rating by Deutsche Bank on Tuesday, January 26. The stock of Bank of America Corporation (NYSE:BAC) has “Outperform” rating given on Tuesday, October 6 by Oppenheimer. BMO Capital Markets maintained Bank of America Corporation (NYSE:BAC) rating on Wednesday, August 23. BMO Capital Markets has “Hold” rating and $27.0 target.

Analysts await Bank of America Corporation (NYSE:BAC) to report earnings on July, 17. They expect $0.63 earnings per share, up 36.96% or $0.17 from last year’s $0.46 per share. BAC’s profit will be $6.39B for 11.50 P/E if the $0.63 EPS becomes a reality. After $0.62 actual earnings per share reported by Bank of America Corporation for the previous quarter, Wall Street now forecasts 1.61% EPS growth.

Investors sentiment decreased to 0.95 in 2018 Q1. Its down 0.24, from 1.19 in 2017Q4. It fall, as 73 investors sold BAC shares while 633 reduced holdings. 134 funds opened positions while 535 raised stakes. 6.66 billion shares or 2.67% less from 6.85 billion shares in 2017Q4 were reported. Crestwood Advsr Gp Limited Liability Co invested in 883,921 shares or 2.08% of the stock. Brick & Kyle Associates reported 46,220 shares or 1.12% of all its holdings. Norinchukin Bancorp The invested 0.3% in Bank of America Corporation (NYSE:BAC). Interocean Capital Ltd Co reported 348,617 shares or 1.39% of all its holdings. First Merchants Corp reported 0.05% of its portfolio in Bank of America Corporation (NYSE:BAC). Asset Advisors holds 6,102 shares. Integral Derivatives Limited Liability Corp reported 0.03% of its portfolio in Bank of America Corporation (NYSE:BAC). Lee Danner Bass has invested 0.1% in Bank of America Corporation (NYSE:BAC). Clark Capital Group holds 1.24 million shares. Loomis Sayles & LP invested in 0.17% or 2.72M shares. Donaldson Capital Mngmt Limited Liability holds 20,149 shares or 0.06% of its portfolio. Oakworth Cap Inc reported 158,984 shares. 47,975 were reported by Gardner Russo Gardner Limited Liability Co. Captrust Finance Advsrs stated it has 306,004 shares. Menlo Advisors Lc holds 175,930 shares.

Oregon Public Employees Retirement Fund, which manages about $6.62B US Long portfolio, upped its stake in Intact Financial Corp by 37,726 shares to 56,346 shares, valued at $4.23M in 2018Q1, according to the filing. It also increased its holding in Bristol Myers Squibb Co (NYSE:BMY) by 7,134 shares in the quarter, for a total of 403,521 shares, and has risen its stake in Avery Dennison Corp (NYSE:AVY).

Bank of America Corporation (NYSE:BAC) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *